Showing results (701-710 of 4,871) with videos related to

Sort By:
Pageof 488
Urologic Oncology|July 9, 2010
Considerations on implementing diagnostic markers into clinical decision making in bladder cancerYair Lotan, Shahrokh F Shariat, Bernd J Schmitz-Dräger, et al.
Urologic Oncology|August 31, 2010
Dutasteride monotherapy in men with serologic relapse following radical therapy for adenocarcinoma of the prostate: a pilot studyMichael Perrotti, Ritu Jain, Linda M Abriel, et al.
Urologic Oncology|August 31, 2010
Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physiciansGregory E Tasian, Matthew R Cooperberg, Janet E Cowan, et al.
Urologic Oncology|September 9, 2010
Oncogenic role of fibroblast growth factor receptor 3 in tumorigenesis of urinary bladder cancerArshad A Pandith, Zafar A Shah, Mushtaq A Siddiqi
Urologic Oncology|September 9, 2010
The effect of minimally invasive and open radical prostatectomy surgeon volumeWesley W Choi, Xiangmei Gu, Stuart R Lipsitz, et al.
Urologic Oncology|September 9, 2010
Recurrent seminomas: clinical features and biologic implicationsAvik Som, Rui Zhu, Charles C Guo, et al.
Urologic Oncology|September 9, 2010
Are cell cycle and apoptosis genes associated with prostate cancer risk in North Indian population?Raju Kumar Mandal, Rama Devi Mittal
Urologic Oncology|September 9, 2010
CA9 as a molecular marker for differential diagnosis of cystic renal tumorsGuorong Li, Issam Bilal, Anne Gentil-Perret, et al.
Urologic Oncology|September 7, 2010
Focal therapy for prostate cancer: fact or fiction?Emilie Lecornet, Caroline Moore, Hashim Uddin Ahmed, et al.
Urologic Oncology|September 11, 2007
Proteases, growth factors, chemokines, and the microenvironment in prostate cancer bone metastasisR Daniel Bonfil, Sreenivasa Chinni, Rafael Fridman, et al.
Pageof 488